Home/Filings/4/0001437749-25-038139
4//SEC Filing

Hendricks Diane 4

Accession 0001437749-25-038139

CIK 0001645469other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 3:42 PM ET

Size

6.2 KB

Accession

0001437749-25-038139

Insider Transaction Report

Form 4
Period: 2025-12-16
Transactions
  • Other

    Common Stock

    2025-12-1643,499567,580 total(indirect: See footnote)
Holdings
  • Common Stock

    (indirect: See footnote)
    93,750
Footnotes (2)
  • [F1]Reported disposition relates to pro rata distribution by Gem Pharmaceuticals, LLC ("Gem") to its members in which the reporting person has no pecuniary interest. Pharma Investments LLC ("Pharma") owns a controlling share of Gem and the reporting person, a manager of Gem, owns a controlling share of Pharma, so Pharma and its controlling shareholders have indirect control over the securities described herein. The managers of Gem and the controlling shareholders of Pharma each disclaim ownership of the shares of common stock owned by Gem, except to the extent of their pecuniary interest therein.
  • [F2]This is based upon the 93,750 shares of Monopar Common Stock that DMH Business LLC directly owns. As a manager of DMH Business LLC, Ms. Hendricks may be deemed to share voting and dispositive power over these 93,750 shares. Ms. Hendricks disclaims beneficial ownership of the 93,750 shares held by DMH Business LLC, except to the extent of her pecuniary interest therein.

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001727478

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 3:42 PM ET
Size
6.2 KB